Chemical Structure : SP2509
CAS No.: 1423715-09-6
Catalog No.: PC-43122Not For Human Use, Lab Use Only.
SP2509 is a potent, selective histone demethylase LSD1 (KDM1A) inhibitor with IC50 of 13 nM, shows no activity against MAOA, MAOB, LDH and glucose oxidase.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | $358 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SP2509 is a potent, selective histone demethylase LSD1 (KDM1A) inhibitor with IC50 of 13 nM, shows no activity against MAOA, MAOB, LDH and glucose oxidase.
SP2509 inhibits the colony growth of OCI-AML3 significantly more than of the other AML cell-types, induces more apoptosis of AML cells expressing mutant NPM1 than mixed-lineage leukemia fusion oncoproteins.
SP2509 significantly improves the survival of immune-depleted mice model of AML.
SP2509 is synergistically lethal against cultured and primary AML blasts combined with panobinostat.
M.Wt | 437.8972 | |
Formula | C19H20ClN3O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 33 mg/mL |
|
Chemical Name/SMILES |
(E)-N'-(1-(5-Chloro-2-hydroxyphenyl)ethylidene)-3-(morpholinosulfonyl)benzohydrazide |
1. Fiskus W, et al. Leukemia. 2014 Nov;28(11):2155-64.
2. Sonnemann J, et al. Br J Haematol. 2017 Dec 3. doi: 10.1111/bjh.14983.
3. Sehrawat A, et al. Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 201719168.
4. Khanal T, et al. Sci Rep. 2017 Sep 6;7(1):10662.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright